Novartis interim results from global, pivotal CTL019 trial show durable complete responses in adults with r/r DLBCL

Novartis interim results from global, pivotal CTL019 trial show durable complete responses in adults with r/r DLBCL

Jun 07, 2017

Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl-0